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Abstract: Principal component analysis (PCA) is routinely applied to the study of NMR based metabolomic data.
PCA is used to simplify the examination of complex metabolite mixtures obtained from biological samples that may
be composed of hundreds or thousands of chemical components. PCA is primarily used to identify relative changes in
the concentration of metabolites to identify trends or characteristics within the NMR data that permits discrimination
between various samples that differ in their source or treatment. A common concern with PCA of NMR data is the
potential over emphasis of small changes in high concentration metabolites that would over-shadow significant and
large changes in low-concentration components that may lead to a skewed or irrelevant clustering of the NMR data.
We have identified an additional concern, very small and random fluctuations within the noise of the NMR spectrum
can also result in large and irrelevant variations in the PCA clustering. Alleviation of this problem is obtained by simply excluding the noise region from the PCA by a judicious choice of a threshold above the spectral noise.
Keywords: Principal component analysis, Metabolomics, Impact of noise, NMR

1. Introduction

[4], [8], [9], [10] and [11] and (3) explore in vivo protein
function and activity [3], [12], [13] and [14]. 1H NMR
spectrum collected on the entire metabolome obtained
from whole cell lysis or biofluids tend to be extremely
complex due to the presence of hundreds of low-molecular weight compounds. Visual inspection or a spectral
difference to identify metabolite concentration changes
is relatively cumbersome if not generally impractical for
large sample sizes. Instead, principal component analysis (PCA) is typically used to decipher changes in NMR
based metabolomic data [15] and [16]. PCA is a well established statistical technique that determines the directions of largest variations in the data set, where a metabolomic data set is composed of a series of NMR spectra
collected from numerous cell extracts or biofluid samples. The data are generally presented as a two or threedimensional plot (scores plot) where the coordinate axis
correspond to the principal components (representing
the directions of the two or three largest variations in the
data set). Effectively, each NMR spectrum is reduced to

NMR is an extremely versatile analytical tool where the
utility of NMR has recently been expanded to include the
analysis of the metabolome [1]. Metabolomics is a natural extension of genomics and proteomics where the particular state or activity of a cell is monitored through the
quantization of the low-molecular weight molecules present in the cell instead of directly following gene or protein expression levels [2]. Metabolomics has an intrinsic
advantage over genomics and proteomics analysis since
observed changes in the metabolome are directly coupled with changes in protein activity and cell function. A
simple change in the expression level of a gene or protein does not necessarily correlate directly with a change
in the activity level of a protein [3].
NMR is routinely being applied to monitor changes
in the composition and concentration of metabolites
found in biofluids and cell extracts to: (1) monitor drug
toxicity [4], [5], [6] and [7], (2) identify disease markers
88
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a single point in the PC coordinate axis, where similar
spectra will cluster together and variations along any of
the PC axes will highlight experimental differences between the spectra.
The success of the application of PCA in the analysis of NMR metabolomic data is intrinsically dependent
on the consistency of sample and data handling [17]. Any
observed variations in the NMR data should be related to
the state of the cell and organism, as opposed to subtle
changes in chemical shifts, line-widths, baseline or artifacts from processing. To minimize these affects and to
simplify data handling, NMR spectral data are usually divided into buckets with widths of 0.01–0.04 ppm [18] and
[19]. This tends to smooth out errors from fluctuations
in chemical shifts and line-shape between NMR spectra
caused by sample handling or preparation. Another similar concern is the impact of changes in abundant metabolites relative to changes in the majority of low-concentration chemicals [20]. A relatively small random change
in the concentration of an abundant metabolite would still
result in an apparent large intensity change that may potentially mask a functionally relevant change in a lowconcentration metabolite. The negative impact on the
PCA scores plot would be an undesirable clustering of the
NMR data that emphasized the irrelevant random changes
of the abundant metabolite instead of the changes associated with the functionally relevant low-concentration metabolites. To minimize this issue, a transformation of the
original data is performed that enhances the intensity of
weak peaks relative to strong peaks and generates a constant variance in the data [10] and [21].
In this article, we describe the observation of another
potential source of error in PCA of NMR metabolomic
data that resulted in poor clustering of “ideal” NMR data
with high similarity. The source of this error is the conceptual opposite of the random fluctuations of intense signals from abundant metabolites described above and as a
result was completely unexpected. Extremely small variations within the noise of high signal-to-noise NMR spectra had a significantly and surprisingly negative impact in
the quality of the clustering in PCA scores plot.
2. Materials and methods
2.1. NMR data collection
The NMR metabolomics test data sets consisted of three
individual samples composed of either 500 mM or 1 mM
of (i) ATP, (ii) glucose, and (iii) ATP and glucose. The
compounds were dissolved in 99.8% D2O with 50 mM
phosphate buffer at pH 7.2 (uncorrected) and 5 mM of
TMSP. The NMR spectra were collected on a Bruker
500 MHz Avance spectrometer equipped with a triple-resonance, z-axis gradient cryoprobe. 1H NMR spectra were
collected with 128 transients at 298 K with solvent presat-
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uration of the residual HDO, a sweep-width of 5482 Hz
and 32 K data points. Ten duplicate 1H NMR spectra were
collected sequentially for each of the three samples for a
data set consisting of 30 NMR spectra for both the 1 and
500 mM set of samples.
2.2. Statistical analysis
The two sets of 30 NMR spectra were processed automatically using a macro in the ACD/1D NMR manager (Advanced Chemistry Development, Toronto, Ontario). The
NMR data were Fourier transformed, zero-filled, phased
and baseline corrected. The NMR spectra were processed
using multiple protocols to eliminate the possible contribution of data processing to the observed spread in the
PCA. The NMR spectra were processed with zero, one
and four zero-fillings. The baseline was corrected using spectrum averaging or a polynomial fit of the noise.
For spectrum averaging, the spectrum regions that do not
contain signals are automatically defined by using a rectangular box (box half-width of 30 points). A peak is defined as having intensity 5-times greater than the noise
standard deviation, where noise is defined as the minimal
Root Mean Square error. The baseline is constructed by
averaging the spectrum curve over these regions. Similarly, for polynomial fit the spectrum is equally divided
into 64 regions. A polynomial of order 4 is fit to the regions that only contain noise. The polynomial is then subtracted from the entire spectrum.
The residual H2O NMR resonance between 4.87 and
5.13 ppm was set to zero and excluded from the bucketing and PCA analysis. Each spectrum was referenced with
the TMSP peak set to 0.0 ppm. A table of integral intensities bucketed into bins with a width of 0.025 or 0.04 ppm
using the ACD intelligent or standard bucketing schemes
were then exported to MS Excel. Instead of using a uniform bucket size of 0.025 or 0.04 ppm throughout the
spectrum, the ACD intelligent bucketing protocol places
the bucket divisions at local minima within the spectrum to avoid the splitting of peaks between buckets. The
smaller bucketing size of 0.025 ppm resulted in a slightly
better clustering of the data (see Supplemental Figs. 1S
and 2S). There is a 1.48% improvement along P1, and
0.12% improvement along P2 in the variance using the
0.025 ppm bucketing size. An MS Excel macro was then
used to combine the 30 spectra into a single file to normalize the binned intensities to a total integrated intensity of 1.0. The Excel spreadsheet was then imported into
SIMCA (UMETRICS, Kinnelon, NJ) for PCA. Exclusion
of the noise regions of the 1H NMR spectra was accomplished by either limiting the bucket analysis in ACD/1D
NMR manager to regions of the NMR spectrum that contained manually defined peaks or by an Excel macro that
set the value of every bin below a certain intensity threshold to zero.
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3. Results and discussion
3.1. Principal component analysis of simulated metabolomic data
As a starting point to familiarize ourselves with the application of principal component analysis (PCA) of NMR
based metabolomics data, we initiated a pilot study of
simulated metabolomic data. The simulated metabolomic data simply consisted of three NMR samples composed of ATP, glucose and an ATP–glucose mixture. To
optimize the similarity in the experimental data, duplicate NMR spectra were collected using the same sample. This provided us with a data set that was expected
to yield tight clustering among the repeat data sets and
known variances between the three unique samples.
The first comparison made was between the ATP and
the ATP–glucose mixture samples. Again, we anticipated
the major variance observed along PC1 would be attributed to the glucose NMR signals. Similarly, the variance
along PC2 was expected to be attributed to instrument
instability. We expected to see a relatively large variance along the PC1 axis and a tighter cluster along PC2.
The PCA scores plot of the ATP and ATP–glucose mixture samples is illustrated in Fig. 1.To our surprise, we
observed a relatively large scattering along PC2, equivalent in magnitude to the separation in PC1, but even more
troubling was the observation that one of the ATP spectrum (#2) fell outside the 95% confidence level in the PCA
plot. This observation was clearly a point of confusion. If
this was a “normal” experimental data set, the PCA would
flag this data point as an outlier and raise concerns of the
origin of this sample, but in our simulated data set this is
not a possibility. The samples are all identical. An alternative explanation that may have lead to this outlier would
be a failure in either the data collection or the processing
of the NMR spectrum.
The success of PCA of NMR metabolomics data is
intrinsically tied to the consistency in the handling, preparation, collection, and processing of the NMR data [17].
Problems in phasing, referencing, baseline correction or

Halouska and Powers in Journal of Magnetic Resonance 178 (2006)

instrument stability would easily lead to the observed
scatter and the outlier seen along PC2. But, if any of these
problems were present it would also result in a similar
scatter along PC1. This is clearly not the case. It is also
apparent that these processing or acquisition problems are
not present by visually inspecting the NMR spectra. Fig.
2 compares the outlier ATP spectrum (#2) against the ATP
spectrum (#9), which has a minimal variation along PC2.
There is no visual difference between these two spectra
that would easily justify the large difference along PC2.

Fig. 2. 1H NMR spectra of the (A) outlier ATP (#2) spectrum
and (B) ATP (#9) spectrum with minimal variation along
PC2.

Fig. 1. PCA scoring plots
of the set of 10 ATP ( )
and ATP–glucose (•) NMR
spectra.
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To further verify that the processing protocol did not
contribute to the large variations along PC2, the data were
processed by varying the type of baseline correction, the
number of zero-fillings, bucket width, and the method of
binning (see Supplemental Figs. 1S–6S). Reducing the
bucket width from 0.04 to 0.025 ppm did result in a small
improvement in the scattering, with a 1.48% improvement
along PC1 and a 0.12% improvement along PC2. Changing the baseline correction from a polynomial fit to spectral averaging or changing the number of zero-filling from
zero to four or changing the binning method from intelligent bucketing to standard bucketing either had no beneficial effect or increased the PC2 variation. Interestingly,
the specific characteristics of the PCA scores plots (absolute position of data points along the PC1 and PC2 axis)
were sensitive to the details of the processing parameters
even though the general appearance of each NMR spectrum was unchanged.
It is also conceivable that the relatively high sample
concentration of 500 mM may have inadvertently contributed to the PC2 variation. To address this issue, the experiments were repeated exactly as before where the ATP,
glucose and ATP–glucose concentrations were reduced to
1 mM. Essentially identical results were observed with
the lower concentration samples (see Supplemental Figs.
7S–10S). This clearly indicates that sample concentration
is not the source of the PC2 variation.
It is also interesting to note that the relatively more
complicated ATP–glucose NMR spectra experiences a
significantly smaller PC2 fluctuation compared to the ATP
NMR spectra. This suggests that the observed PC2 variation is not primarily related to instrument stability since
an opposite result would be expected. Simply, the larger
number of NMR peaks present in the ATP–glucose spectrum increases the probability that a random fluctuation
in peak intensity caused by instrument instability would
occur between sequential data collection. Effectively, the
ATP–glucose sample contains more probes to monitor instrument stability.
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3.2. Difference loadings plot analysis of simulated metabolomic data
Comparison of the PC2 loading plots between the outlier
ATP (#2) spectrum and the ATP spectrum (#9), which has
a minimal variation along PC2, identifies the surprising
source of the spread along PC2 (Fig. 3). The NMR bins
that are responsible for most of the differentiation along
PC2 are primarily associated with noise regions in the
spectrum. Even more startling is the fact that the relative
fluctuation in the intensity of these noise bins is extremely
small compared to the intensity of real peaks in the spectrum. Fig. 4 illustrates an expanded view of one of the
noise regions of the outlier ATP spectrum (#2) compared
against the ATP spectrum (#9), which has a minimal variation along PC2. This expanded noise region of the NMR
spectrum contains a large positive variation in the difference loadings plot (bin 363, 7.82–7.83 ppm), boxed area
in Fig. 3. The expanded noise region does illustrate some
random spikes in the noise that exhibit intensities greater
than the average noise bands. These noise spikes are consistent with normal and expected variations in the instrument noise, and appear to correlate with the large variations observed in the PC2 loading plot. Nevertheless, the
magnitude of the noise spikes and PC2 loadings do not
appear to correlate. The largest PC2 loading for bin 363
(7.82–7.83 ppm) is 15, but the noise spike is lower in intensity compared to the spikes at 8.00 and 8.03 ppm,
which have corresponding PC2 loadings that range from
1 to 4. It is also important to keep the relative magnitude
of these noise spikes in perspective with the remainder
of the NMR spectrum. The relative intensity of the noise
compared to real peaks, including 13C satellites, is effectively zero (Fig. 3). On this scale, the relative intensity of
the noise spikes compared to the typical noise band would
be expected to be inconsequential and irrelevant. Table 1
lists some of the intensity values in the NMR noise bins
that are responsible for the outlier ATP spectrum (#2) with
corresponding values for other ATP spectra. Again, the in-

Fig. 3. PCA loading plots difference from the comparison of
the outlier ATP (#2) spectrum
and an ATP (#9) spectrum with
minimal variation along PC2.
The boxed area corresponds to
the expanded noise regions illustrated in Fig. 4.
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Fig. 4. Expanded view of the
1H NMR noise region for the
(A) outlier ATP (#2) spectrum
and (B) ATP (#9) spectrum with
minimal variation along PC2.

Table 1. Select intensity values of NMR noise after binning and normalization

a

Subset of the noise displayed in Fig. 4. The list of binned noise is centered around the largest positive peak (bin 363, 7.82–7.83 ppm) in the boxed region of Fig. 3.
b Binned noise for the outlier ATP spectrum number 2.
c Binned noise for the ATP spectrum with minimal variation along PC2.

tensity of these noise bins is effectively zero with small
random fluctuations about 10−5–10−7, where some values
are exactly zero. A large PC2 loading value was observed
for bin 363 in ATP spectrum #2, where the intensity of this
bin is 1.04 e−5 in spectrum #2 but varies from 0 to 1.43 e−7.
Apparently, since bin 363 for most of the ATP spectra is 0,
a large PC2 loading value is attributed to ATP spectrum #2
because of a large relative difference even though the absolute difference is infinitesimal.
The contribution of noise to the difference loadings
plot was not unique to the comparison of ATP spectra #2
and #9. Similar results were observed when other spectra
were compared (see Supplementary Fig. 11S). The major
differences in the difference loading plots were associated
with noise regions, but the specific characteristics of the
difference loadings plots varied randomly. The position
and intensity of the spikes varied between the difference
loadings plots. Again, this is consistent with the variability observed along PC2 in the PCA scores plot (Fig. 1)
and the expected variability of noise. Clearly, these observations imply that the presence of noise may be detrimental to accurate clustering in NMR PCA scores plot.

3.3. Principal component analysis with a noise threshold
Assuming that the difference loadings plot analysis
correctly identified that the PC2 variation is due to these
extremely small fluctuations in noise regions of the spectrum and not another artifact of the PCA, the ATP and
ATP–glucose NMR spectra were re-analyzed with the exclusion of noise from the binning. This was accomplished
by either binning regions of the NMR spectrum that only
contained peaks or by setting all bins that are below a
certain intensity threshold to exactly zero. The PCA improved with the exclusion of the noise. None of the spectra fall outside the 95% confidence level and the relative
range of variation along the PC2 axis have been reduced
by a factor of 4–5 for the ATP spectra (Fig. 5). Similarly, the percent variance significantly increased for PC1
from 33.12 ± 10.31 to 83.37 ± 7.44% with the exclusion
of noise. The contribution of noise to the scores plot was
also evident by comparing 1 mM ATP NMR spectra with
500 mM ATP–glucose spectra. The same variance along
PC2 was present for 1 mM ATP spectra that was similarly
reduced by a 4- to 5-fold by the exclusion of the noise.
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Fig. 5. PCA scoring plots of the set of 10 ATP ( ) and ATP–glucose (•) NMR spectra after removal of the spectral noise by
only binning NMR resonances.

Conversely, 500 mM ATP–glucose spectra were tightly
clustered even with the inclusion of noise because of the
relatively high signal-to-noise of 500 mM ATP–glucose
NMR spectra compared to 1 mM ATP spectra (see Supplemental Figs. 12S–13S and Table 1S). Again, the variance along PC2 is directly correlated to the presence of
noise in the NMR spectrum.
The noise component of an NMR spectrum does not
convey any valuable information in the analysis of metabolomic data, but it is routinely included to simplify the
data handling. This was based on the reasonable assumption that the inclusion of noise in the binning of NMR
spectra would have a neutral impact on the PCA, where
the binning process itself would minimize the noise intensity and its variation. The largest variations expected to
be identified in PCA would be changes in the intensity of
various metabolite NMR resonances. Unfortunately, our
analysis indicates that small random changes in spectral
noise may contribute to large incorrectly perceived variations in NMR spectra.

3.4. PCA including the glucose NMR data with and without a noise threshold
To determine if the observed large variation along the PC2
axis was an artifact created by comparing just two distinct
and tightly clustered data sets, we added a third related
NMR sample to the analysis. The third NMR sample only
contains glucose and is expected to induce a significant
PC2 variation in the PCA score plot. The PCA scores plot
of the ATP, glucose and ATP–glucose NMR samples is illustrated in Fig. 6.As expected, large PC1 and PC2 variations result from the different composition of the three
NMR spectra, effectively forming an equilateral triangle in the scores plot. The separation along either PC1
or PC2 is considerably larger than the variability among
any members in the three distinct clusters. Nevertheless,
the inclusion of the NMR noise region still results in a
noticeable spread among the repeat NMR spectra within
each cluster, especially for the ATP and glucose samples
(Fig. 6A). The larger spread for the ATP and glucose samples is consistent with the fact that these NMR spectra

Fig. 6. PCA scoring plots of the 10 ATP ( ) ATP–glucose (•) and glucose ( ) NMR spectra with the (A) inclusion and (B) exclusion of noise.
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would have more noise regions relative to the ATP–glucose spectra. Removal of the NMR noise regions results
in a significant improvement in the clustering pattern in
the PCA scores plot (Fig. 6B). As initially expected, the
repeat NMR spectra are essentially on top of each other in
each of the three clusters. Clearly, the inclusion of NMR
noise regions results in a significant spread in the clustering of the PCA scores, where the noise does not correlate
with any relevant sample characteristics.
In this “ideal” NMR metabolomic data, the large separation present in PC1 and PC2 permits easy discrimination of the ATP, glucose and ATP–glucose spectra despite
the observed spread within each cluster caused by the
presence of noise. Generally, this would not be the case
when dealing with “real” biological data obtained from
numerous cell lysis or biofluid samples. Thus, the level
of discrimination expected from a set of typical NMR
based metabolomic data may be compromised by the inclusion of NMR noise. The irrelevant spread in clustering induced by NMR noise may actually obscure the underlying features in the data resulting in the loss of any
informative clustering in the PCA scores plot. Therefore,
the standard protocol for processing NMR data for PCA
should include the exclusion of noise especially since the
noise provides no valuable information while potentially
distorting the proper analysis of the NMR data.
Since, biofluid or cell extract data may contain weak
NMR resonances that may be associated with functionally
important metabolites, the choice of an appropriate noise
threshold is critical to avoid the inadvertent elimination
of these potentially valuable peaks. An iterative approach
that adjusts the noise threshold to minimize the spread between repeat data points while simultaneously maximizing the separation between data collected under various
cellular conditions may provide a mechanism to remove
the negative impact of noise without compromising the
data. A threshold corresponding to one standard deviation of the noise would be a reasonable starting point for
the iterative approach where an upper-limit less than 2–3
times the noise would avoid eliminating peaks that can be
reliably differentiated from the noise band.
4. Conclusion
The principal component analysis of NMR metabolomic
data is proving to be a powerful tool for the evaluation
of toxicity, protein function, and the identification of disease markers. A fundamental benefit of PCA is the identification of distinct clusters in a scores plot that highlights discriminating characteristics reflecting the source
or treatment of the NMR samples. Essential to the successful interpretation of NMR PCA data is a requirement
that the observed variations identified by PCA are related to features of the biological sample and not an ar-
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tifact of data manipulation or sample handling. Processing NMR data for PCA generally includes binning the
entire spectrum, which also incorporates all the noise regions. Our analysis of “ideal” metabolomic data indicates that this inclusion of noise may result in significant and irrelevant spreading of the PCA scores clusters
that may inhibit proper interpretation of the data. A simple solution is a routine application of a filter to exclude
the noise region below a defined peak intensity threshold.
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Supplementary Material: “Negative Impact of Noise on the Principal Component
Analysis of NMR Data” Steven Halouska and Robert Powers

Figure 1S: PCA scoring plot of set of ten 500mM ATP ( ) and 500mMATP-glucose (●)
NMR spectra using intelligent bucketing with bin size of .025 ppm.

Figure 2S: PCA scoring plot of set of ten 500mM ATP ( ) and 500mM ATP-glucose (●)
NMR spectra using intelligent bucketing with bin size of .040 ppm.

Figure 3S: PCA scoring plot of set of ten 500mM ATP ( ) and 500mM ATP-glucose (●)
NMR spectra using standard bucketing with bin size of .025 ppm.

Figure 4S: PCA scoring plot of set of ten 500mM ATP ( ) and 500mM ATP-glucose (●)
NMR spectra with 1X zero filling.

Figure 5S: PCA scoring plot of set of ten 500mM ATP ( ) and 500mM ATP-glucose (●)
NMR spectra with 4X zero filling.

Figure 6S: PCA scoring plot of set of ten 500mM ATP ( ) and 500 mM ATP-glucose
(●) NMR spectra with polynomial baseline correction

Figure 7S: PCA scoring plot of set of ten 1mM ATP ( ) and 1mM ATP-glucose (●)
NMR spectra using intelligent bucketing with bin size of .025 ppm.

Figure 8S: PCA scoring plot of set of ten 1mM ATP ( ) and 1mM ATP-glucose (●)
NMR, editing out the noise.

Figure 9S: PCA scoring plot of set of ten 1mM ATP ( ), 1mM ATP-glucose (●), and
1mM glucose (●) NMR spectra using intelligent bucketing with bin size of .025 ppm

Figure 10S: PCA scoring plot of set of ten 1mM ATP ( ), 1mM ATP-glucose (●), and
1mM glucose (●) NMR spectra, editing out the noise

(a)

(b)

Figure 11S: (a) PCA loading plots difference from the comparison of the ATP (#3)
spectrum and the ATP (#9) spectrum with minimal variation along PC2. (b) PCA scoring
plots of the set of ten ATP ( ) and ATP-glucose (●) NMR spectra. ATP spectra #3 and #9
are labeled to indicated their relative positioning in the PCA scores plot.

Figure 12S: PCA scoring plot of set of ten 1 mM ATP ( ) and 500 mM ATP-glucose (●).

Figure 13S: PCA scoring plot of set of ten 1 mM ATP ( ) and 500 mM ATP-glucose (●),
editing out the noise.

Table 1S: Percent variance of the principal component analysis for the various NMR
data with the inclusion or exclusion of noise regions.
NMR Sample Set
500mM ATP & ATP-Glucose with noise
500mM ATP & ATP-Glucose signal only
500mM ATP & Glucose & ATP-Glucose with noise
500mM ATP & Glucose & ATP-Glucose signal only
1mM ATP & ATP-Glucose with noise
1mM ATP & ATP-Glucose signal only
1mM ATP & Glucose & ATP-Glucose with noise
1mM ATP & Glucose & ATP-Glucose signal only

Percent Variance
PC1
PC2
42.89%
5.95%
90.64%
4.15%
31.46%
13.84%
74.41%
24.86%
38.74%
6.20%
88.19%
10.96%
19.38%
7.73%
80.24%
9.87%

